Facts and figures

Headquarters

Denmark


International

16 production sites on 5 continents.

Affiliates or offices in 77 countries.

Products marketed in more than 165 countries.


Workforce

Approximately 42,000 employees (March 2017).

Approximately 42% of employees are located in Denmark (17,804) and 58% in the rest of the world (North America 6,321 and in International Operations, 4,296  in Europe, 6,321 in Africa, Asia, Middle East & Oceania, 4,371 Region China, 1,777 in Latin America and 1,179 in Japan & Korea).
 
20% within research and development
32% in production and production administration
36% in international sales and marketing
12% in administration

Product areas

We have five product areas:
Diabetes care
Obesity and weight management
Haemophilia management
Growth hormone therapy
Hormone replacement therapy

According to applicable law, only health care professionals are allowed to access product information on our site. Please find the information under Health Care Professionals.

For patient and disease information, including pens and needles, please look under Patients.


Quarterly sale
 

28,452 million Danish kroner Q1 2017

Annual sale

111,780 million Danish kroner 
(Full year results 2016. See Financial Statement for more information)


Sales by business segment
Q1 2017

Diabetes and obesity care total:
23,761 million Danish kroner

Biopharmaceuticals total:
4,691 million Danish kroner


Sales by region
Q1 2017

North America Operations:
14,940 million Danish kroner

USA: 14,402 million Danish kroner
 

International Operations:
13,512 million Danish kroner

Region Europe: 5,226 million Danish kroner
Region AAMEO: 2,964 million Danish kroner
Region China: 3,060 million Danish kroner
Region Japan & Korea: 1,467 million Danish kroner
Region Latin America: 795 million Danish kroner

 


Novo Nordisk A/S

Bagsværd, Denmark, 
CVR nr. 24 25 67 90

 

 


Financial highlights

Download annual reports, interim reports,
investor presentations and more.

Download centre
 


Share information

Learn more about Novo Nordisk shares.

Shareholder rights
 


Novo Nordisk products

Facts about Novo Nordisk products

Product facts